Fig. 4From: Pharmacokinetic and pharmacodynamic analyses of terlipressin in patients with hepatorenal syndromeSimulated terlipressin and L-VP plasma concentrations at steady state following terlipressin 1 mg administered every 6 h in patients with HRS with different body weights. The solid blue line indicates the Loess fitting and the shaded area indicates the 90% confidence interval. Conc, concentration; HRS, hepatorenal syndrome; L-VP, lysine-vasopressin; Q6h, every 6 h; SS, steady-state. Back to article page